Hence, any form of TLR4 hypersensitivity that may exist in MS patient cells appears to be restricted to the pathway leading to TNF-α expression, and further studies will probe the intracellular signaling events in patient cells. This evidence concerns the gene TLR4 and myeloid sarcoma.